Study of pharmacodynamic and pharmacokinetic-mediated genetic susceptibility to drug-induced arrhythmia and sudden cardiac death

被引：0

作者：

Martinez-Matilla, M. ^{[1
]}

Blanco-Verea, A. ^{[1
]}

Torres, M. ^{[2
]}

Ramos-Luis, E. ^{[1
]}

Gil, R. ^{[1
]}

Bermejo, A. ^{[3
]}

Hirata, M. H. ^{[4
]}

Brisighelli, F. ^{[5
]}

Paramo, M. ^{[6
]}

Carracedo, A. ^{[7
]}

Brion, M. ^{[1
]}

机构：

[1] USC, Inst Invest Sanitaria Santiago, Xenet Enfermidades Cardiovasc & Oftalmolox, Grp Med Xenom, Santiago De Compostela, Spain

[2] Univ Santiago de Compostela, CeGen Genotyping Natl Ctr, Grp Med Xenom, Santiago De Compostela, Spain

[3] Univ Santiago de Compostela, Inst Ciencias Forens Luis Concheiro, INCIFOR, Santiago De Compostela, Spain

[4] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil

[5] Univ Cattolica Sacro Cuore, Forens Gen Lab, Inst Legal Med, Rome, Italy

[6] Univ Hosp Santiago de Compostela, Serv Psiquiatria, Santiago De Compostela, Spain

[7] Univ Santiago de Compostela USC, Inst Invest Sanitaria Santiago, Grp Med Xenom, Santiago De Compostela, Spain

来源：

EUROPEAN HEART JOURNAL | 2017年 / 38卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P5857

引用

页码：1241 / 1241

页数：1

共 50 条

[41] A cardiac ion channel (KVLQTI) mutation predisposes to drug-induced arrhythmla: Direct evidence of genetic susceptibility to an acquired disorder
Baumbach, LL
Miller, T
Estrella, E
Ahearn, ME
Kurlansky, P
Myerburg, R
Bishopric, NH
CIRCULATION, 2002, 105 (14) : E92 - E92
[42] Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury
Huang, Yi-Shin
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (01) : 1 - 8
[43] Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes
Ramalho, Diogo
Freitas, Joao
REVISTA PORTUGUESA DE CARDIOLOGIA, 2018, 37 (05) : 435 - 446
[44] Doxapram-mediated Increase in Cardiac Output Reduces Opioid Plasma Concentrations: A Pharmacokinetic/Pharmacodynamic-Pharmacokinetic/Pharmacodynamic Modeling Study in Healthy Volunteers
Roozekrans, M.
Olofsen, E.
van der Schrier, R.
Boom, M.
Mooren, R.
Dahan, A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (01) : 115 - 122
[45] Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study
Gatzoulis, MA
Balaji, S
Webber, SA
Siu, SC
Hokanson, JS
Poile, C
Rosenthal, M
Nakazawa, M
Moller, JH
Gillette, PC
Webb, GD
Redington, AN
LANCET, 2000, 356 (9234): : 975 - 981
[46] Two-dimensional mapping of cardiac action potential duration for assessing the risk of drug-induced arrhythmia
Suzuki, Shingo
Tsujimae, Kenji
Murakami, Shingo
Findlay, Ian
Kurachi, Yoshihisa
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 196P - 196P
[47] Severe hypoglycemia-induced sudden death is mediated by both cardiac arrhythmias and seizures
Reno, Candace M.
Skinner, Allie
Bayles, Justin
Chen, Y. Stefanie
Daphna-Iken, Dorit
Fisher, Simon J.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2018, 315 (02): : E240 - E249
[48] Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes
A H Ramirez
C M Shaffer
J T Delaney
D P Sexton
S E Levy
M J Rieder
D A Nickerson
A L George
D M Roden
The Pharmacogenomics Journal, 2013, 13 : 325 - 329
[49] Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes
Ramirez, A. H.
Shaffer, C. M.
Delaney, J. T.
Sexton, D. P.
Levy, S. E.
Rieder, M. J.
Nickerson, D. A.
George, A. L., Jr.
Roden, D. M.
PHARMACOGENOMICS JOURNAL, 2013, 13 (04): : 325 - 329
[50] Torsade de pointes in coronavirus disease 2019 patient: hypopotassemia, cardiac injury, and drug-induced arrhythmia
Shandy, C. A.
Jayantika, I. G. A. B. K.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)

← 1 2 3 4 5 →